“…Similarly, it is questionable whether the required micromolar concentrations of P-site inhibitors can be obtained in the intact organism without off-target effects (Seifert, 2016). Overall, NKY80, SQ22,536, and vidarabine, which are very widely used as "selective mAC inhibitors" (or even more problematic as "selective AC5 inhibitors") (e.g., Rangel-Barajas et al, 2011; Bravo et al, 2016;Liu and Steketee, 2016;Wada et al, 2016;Wei et al, 2016), should be used with great caution as pharmacological tools, and any observed effects should be carefully checked for off-target actions (Seifert, 2014(Seifert, , 2016. It is particularly important to confirm that the AC inhibitor used actually prevents a GPCR-or FSKmediated cAMP increase (Brunskole Hummel et al, 2013).…”